may have abnormal endocrine activity due to the synthesis and release of catecholamines that predispose to cardiovascular disease. They are typically diagnosed while the disease is localized and ...

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to ...